Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Leukemia 1Hematologic Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Anemia 1

Interventions

fludarabine phosphate 9Cyclophosphamide 8Cyclosporine 7Busulfan 6Antilymphocyte Serum 6fludarabine 5Melphalan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Rivaroxaban 3Radiotherapy 3Methylprednisolone 3Filgrastim 3Cord Blood Stem Cell Transplantation 3thymoglobulin 2ferric carboxymaltose 2apixaban 2Whole-Body Irradiation 2Therapeutics 2Methotrexate 2Heparin, Low-Molecular-Weight 2Hematologic Tests 2Genetic Counseling 2Fondaparinux 2Enoxaparin 2Educational Status 2Drug Therapy 2Dalteparin 2Cytarabine 2sulforaphane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Blood Transfusion × Classical hematology × Clear all
NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Emory University

Phase NA Withdrawn
Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡